ABSTRACT
This editorial elaborates on the current and future applications of linear endoscopic ultrasound (EUS), a substantial diagnostic and therapeutic modality for various anatomical regions. The scope of endosonographic assessment is broad and, among other factors, allows for the evaluation of the mediastinal anatomy and related pathologies, such as mediastinal lymphadenopathy and the staging of central malignant lung lesions. Moreover, EUS assessment has proven more accurate in detecting small lesions missed by standard imaging examinations, such as computed tomography or magnetic resonance imaging. We focus on its current uses in the mediastinum, including lung and esophageal cancer staging, as well as evaluating mediastinal lymphadenopathy and submucosal lesions. The editorial also explores future perspectives of EUS in mediastinal examination, including ultrasound-guided therapies, artificial intelligence integration, advancements in mediastinal modalities, and improved diagnostic approaches for various mediastinal lesions.
Subject(s)
Endosonography , Mediastinum , Humans , Endosonography/methods , Endosonography/trends , Mediastinum/diagnostic imaging , Neoplasm Staging , Mediastinal Neoplasms/diagnostic imaging , Mediastinal Neoplasms/pathology , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/pathology , Mediastinal Diseases/diagnostic imaging , Esophageal Neoplasms/diagnostic imaging , Esophageal Neoplasms/pathology , Lymphadenopathy/diagnostic imaging , Lymphadenopathy/pathology , Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods , Tomography, X-Ray Computed/methods , Tomography, X-Ray Computed/trendsSubject(s)
Drainage , Endosonography , Humans , Drainage/methods , Drainage/instrumentation , Endosonography/methods , Fluoroscopy/methods , Ultrasonography, Interventional/methods , Male , Female , Aged , StentsSubject(s)
Endosonography , Pancreatic Ducts , Humans , Endosonography/methods , Pancreatic Ducts/surgery , Pancreatic Ducts/injuries , Pancreatic Ducts/diagnostic imaging , Ultrasonography, Interventional , Male , Salvage Therapy/methods , Sphincterotomy, Endoscopic/adverse effects , Sphincterotomy, Endoscopic/methods , Ampulla of Vater/surgery , Ampulla of Vater/diagnostic imaging , Aged , Intraoperative Complications/etiology , Intraoperative Complications/surgery , Intraoperative Complications/diagnostic imaging , Female , Middle AgedABSTRACT
Objective: To assess the treatment outcomes of endoscopic ultrasound-guided biliary drainage (EUS-BD) in patients with obstructive jaundice due to unsuccessful endoscopic retrograde cholangiopancreatography (ERCP). Methods: The clinical data of patients with obstructive jaundice who underwent EUS-BD due to ERCP failure at the Gastrointestinal Endoscopy Center of Beijing Friendship Hospital from September 2018 to November 2023, was retrospectively collected and analyzed. We explored the technical success, clinical success, and adverse events associated with EUS-BD. Results: In total, 43 EUS-BD procedures were performed in 39 patients with a technical success rate of 86.0% (37/43). The clinical success rate was 81.1% (30/37). Biliary drainage was not effectively achieved in seven cases, including two fatal cases and five cases of recurrent postoperative biliary obstruction. The incidence of adverse events was 21.6% (8/37), including two cases of postoperative bile leakage peritonitis, two cases of stent displacement, one case of stent dislocation, one case of perforation, and two cases of death. Conclusion: EUS-BD is a relatively safe and effective method for bile duct drainage, serving as a dependable alternative therapeutic option for patients with obstructive jaundice due to unsuccessful ERCP.
Subject(s)
Cholangiopancreatography, Endoscopic Retrograde , Drainage , Endosonography , Jaundice, Obstructive , Humans , Jaundice, Obstructive/etiology , Jaundice, Obstructive/surgery , Drainage/methods , Retrospective Studies , Cholangiopancreatography, Endoscopic Retrograde/methods , Endosonography/methods , Stents , Treatment Outcome , Postoperative Complications , Male , Female , Middle AgedABSTRACT
Endoscopic ultrasound (EUS) has evolved from a diagnostic to an interventional modality, allowing precise vascular access and therapy. EUS-guided vascular access of the portal vein has received increasing attention in recent years as a diagnostic and therapeutic tool. EUS-guided portal pressure gradient directly measures the hepatic vein portal pressure gradient and is crucial for understanding of liver function and prognostication of liver disease. EUS facilitates the sampling of portal venous blood to obtain circulating tumor cells (CTCs) in pancreatobiliary malignancies. This technique aids in the diagnosis and staging of cancers. EUS-guided interventions have a substantial potential for diagnosing portal vein tumor thrombus (PVTT) in patients with hepatocellular carcinoma. EUS-guided coil and glue embolization have higher efficacy for the treatment of gastric varices than direct endoscopic glue. Pseudoaneurysm (PsA), a rare vascular complication of acute and chronic pancreatitis, is typically managed with interventional radiology (IR)-guided embolization and surgery. EUS is increasingly used in specialized centers for non-variceal gastrointestinal bleeding, particularly for pseudoaneurysm-related bleeding. There is limited data on EUS-guided intervention for bleeding ectopic varices, rectal varices and Dieulafoy lesions, but it is becoming more widely accepted. In this extensive review, we evaluated both current and potential future applications of EUS-guided vascular interventions, including EUS-guided gastric variceal bleed therapy, rectal and ectopic varices, pseudoaneurysmal bleeding, splenic artery embolization, portal pressure gradient measurement, portal vein sampling for CTCs, fine needle aspiration of PVTT, intrahepatic portosystemic shunt placement, liver tumor ablation and EUS-guided cardiac intervention.
Subject(s)
Endosonography , Esophageal and Gastric Varices , Gastrointestinal Hemorrhage , Portal Vein , Humans , Endosonography/methods , Gastrointestinal Hemorrhage/therapy , Gastrointestinal Hemorrhage/etiology , Portal Vein/diagnostic imaging , Esophageal and Gastric Varices/therapy , Esophageal and Gastric Varices/diagnostic imaging , Esophageal and Gastric Varices/etiology , Embolization, Therapeutic/methods , Aneurysm, False/therapy , Aneurysm, False/diagnostic imaging , Neoplastic Cells, Circulating , Ultrasonography, Interventional/methods , Liver Neoplasms/therapy , Carcinoma, Hepatocellular/therapy , Carcinoma, Hepatocellular/diagnostic imagingABSTRACT
BACKGROUND: Biliary dilatation without obvious etiology on cross sectional imaging warrants further investigation. This study aimed to assess yield of endoscopic ultrasound in providing etiologic diagnosis in such situation. METHODS: Prospective cohort of consecutive patients with biliary dilatation & non diagnostic computed tomography (CT) and /or magnetic resonance imaging (MRI) underwent endoscopic ultrasound (EUS) with/without fine needle aspiration cytology (FNAC) and were followed clinically, biochemically with/without radiology for up to six months. The findings of EUS were corroborated with histopathology of surgical specimens and endoscopic retrograde cholangiography (ERCP) findings in relevant cases. RESULTS: Median age of 121 patients completing follow up was 55 years. 98.2% patients were symptomatic and median common bile duct (CBD) diameter was 13 mm. EUS was able to identify lesions attributable for biliary dilatation in (67 out of 121) 55.4% cases with ampullary neoplasm being the commonest (29 out of 67 i.e. 43%). Multivariate logistic regression analysis identified jaundice as the predictor of positive diagnosis on EUS, of finding ampullary lesion and pancreatic lesion on EUS. EUS had sensitivity, specificity, positive predictive value and diagnostic accuracy of 95.65%, 94.23%, 95.65% and 95.04% respectively in providing etiologic diagnosis. Threshold value for baseline bilirubin of 10 mg%, for baseline CA 19.9 of 225 u/L and for largest CBD diameter of 16 mm were determined to have specificity of 98%, 95%, 92.5% respectively of finding a positive diagnosis on EUS. CONCLUSION: EUS provides considerable diagnostic yield with high accuracy in biliary dilatation when cross sectional imaging fails to provide etiologic diagnosis.
Subject(s)
Common Bile Duct , Endosonography , Humans , Middle Aged , Male , Female , Endosonography/methods , Prospective Studies , Common Bile Duct/diagnostic imaging , Common Bile Duct/pathology , Aged , Dilatation, Pathologic/diagnostic imaging , Adult , Sensitivity and Specificity , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Aged, 80 and over , Cholangiopancreatography, Endoscopic Retrograde , Common Bile Duct Diseases/diagnostic imaging , Common Bile Duct Diseases/pathologyABSTRACT
BACKGROUND: The diagnosis of peripheral isolated nodular lesions that are suspected as pulmonary tuberculosis (PTB) is challenging, which are not easily accessible via conventional bronchoscopy. This study evaluated the combined use of Xpert MTB/RIF assay and endobronchial ultrasonography with a guide sheath (EBUS-GS) for detecting MTB infection in peripheral lung bands, for early detection of PTB. METHODS: The clinical data of 232 patients with suspected peripheral nodular PTB who underwent EBUS-GS between June 2020 and October 2023 were retrospectively reviewed. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) of acid-fast bacilli smear, culture, Xpert MTB/RIF assay, and pathological examination were calculated. To assess diagnostic accuracy, the results of the four methods were directly compared with the final clinical diagnosis. RESULTS: In total, 146 and 86 patients were clinically diagnosed with peripheral nodular PTB and non-PTB, respectively. The sensitivity, specificity, PPV, NPV, and AUC values of combined Xpert MTB/RIF assay and EBUS-GS were 47.26%, 100.0%, 100.0%, 52.76%, and 0.74; those of acid-fast bacilli smear were 8.22%, 97.67%, 85.71%, 38.53%, and 0.53; those of culture were 31.51%, 100.0%, 100.0%, 46.24%, and 0.66; and those of pathological examination were 23.97%, 97.67%, 94.59%, 43.08%, and 0.61, respectively. CONCLUSION: The diagnostic accuracy of the combined Xpert MTB/RIF assay and EBUS-GS was significantly better than that of other conventional tests. Hence, this novel technique can be routinely applied for diagnosing and managing peripheral nodular PTB.
Subject(s)
Mycobacterium tuberculosis , Sensitivity and Specificity , Tuberculosis, Pulmonary , Humans , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/microbiology , Male , Female , Middle Aged , Retrospective Studies , Mycobacterium tuberculosis/isolation & purification , Mycobacterium tuberculosis/genetics , Adult , Aged , Bronchoscopy/methods , Endosonography/methods , Molecular Diagnostic Techniques/methods , Predictive Value of Tests , Lung/microbiology , Lung/diagnostic imaging , Lung/pathologyABSTRACT
BACKGROUND: Most malignant peripheral pulmonary lesions (PPLs) are situated in the peripheral region of the lung. Although the ultrathin bronchoscope (UTB) can access these areas, a robust navigation system is essential for precise localisation of these small peripheral PPLs. Since many UTB procedures rely on automated virtual bronchoscopic navigation (VBN), this study aims to determine the accuracy and diagnostic yield of the manual bronchial branch tracing (BBT) navigation in UTB-guided radial endobronchial ultrasound (rEBUS) procedures. METHODS: Single-centre retrospective study of UTB-rEBUS patients with PPLs smaller than 3 cm over a two year period. RESULTS: Our cohort consisted of 47 patients with a mean age of 61.6 (SD 9.53) years and a mean target size of 1.91 (SD 0.53) cm. Among these lesions, 46.8% were located in the 6th airway generation, and 78.7% exhibited a direct bronchus sign. Navigation success using BBT was 91.5% based on positive rEBUS identification. The index diagnostic yield was 82.9%, increasing to 91.5% at 12 months of follow-up. Malignant lesions accounted for 65.1% of cases, while 34.9% were non-malignant. The presence of a direct bronchus sign was the sole factor associated with higher navigation success and diagnostic yield. Cryobiopsy outperformed forceps biopsy in non-concentric rEBUS lesions (90.9% vs. 50.0%, p < 0.05), but not in concentric orientated lesions. One pneumothorax occurred in our cohort. CONCLUSIONS: BBT as an exclusive navigation method for small PPLs in UTB-rEBUS procedures has proved to be safe and feasible. Combination of UTB with cryobiopsy remains efficient for eccentric and adjacently oriented rEBUS lesions.
Subject(s)
Bronchoscopy , Endosonography , Lung Neoplasms , Humans , Middle Aged , Bronchoscopy/methods , Male , Female , Retrospective Studies , Aged , Lung Neoplasms/pathology , Lung Neoplasms/diagnostic imaging , Endosonography/methods , Solitary Pulmonary Nodule/pathology , Solitary Pulmonary Nodule/diagnostic imaging , Bronchi/pathology , Bronchi/diagnostic imagingABSTRACT
BACKGROUND: A 3.0-mm ultrathin bronchoscope (UTB) with a 1.7-mm working channel provides better accessibility to peripheral bronchi. A 4.0-mm thin bronchoscope with a larger 2.0-mm working channel facilitates the use of a guide sheath (GS), ensuring repeated sampling from the same location. The 1.1-mm ultrathin cryoprobe has a smaller diameter, overcoming the limitation of the size of biopsy instruments used with UTB. In this study, we compared the endobronchial ultrasound localization rate and diagnostic yield of peripheral lung lesions by cryobiopsy using UTB and thin bronchoscopy combined with GS. METHODS: We retrospectively evaluated 133 patients with peripheral pulmonary lesions with a diameter less than 30 mm who underwent bronchoscopy with either thin bronchoscope or UTB from May 2019 to May 2023. A 3.0-mm UTB combined with rEBUS was used in the UTB group, whereas a 4.0-mm thin bronchoscope combined with rEBUS and GS was used for the thin bronchoscope group. A 1.1-mm ultrathin cryoprobe was used for cryobiopsy in the two groups. RESULTS: Among the 133 patients, peripheral pulmonary nodules in 85 subjects were visualized using r-EBUS. The ultrasound localization rate was significantly higher in the UTB group than in the thin bronchoscope group (96.0% vs. 44.6%, respectively; P < 0.001). The diagnostic yield of cryobiopsy specimens from the UTB group was significantly higher compared to the thin bronchoscope group (54.0% vs. 30.1%, respectively; p = 0.006). Univariate analysis demonstrated that the cryobiopsy diagnostic yields of the UTB group were significantly higher for lesions ≤ 20 mm, benign lesions, upper lobe lesions, lesions located lateral one-third from the hilum, and lesions without bronchus sign. CONCLUSIONS: Ultrathin bronchoscopy combined with cryobiopsy has a superior ultrasound localization rate and diagnostic yield compared to a combination of cryobiopsy and thin bronchoscopy.
Subject(s)
Bronchoscopes , Bronchoscopy , Endosonography , Lung Neoplasms , Humans , Male , Female , Retrospective Studies , Middle Aged , Aged , Bronchoscopy/methods , Bronchoscopy/instrumentation , Endosonography/methods , Endosonography/instrumentation , Lung Neoplasms/pathology , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/diagnosis , Cryosurgery/methods , Cryosurgery/instrumentation , Multiple Pulmonary Nodules/pathology , Multiple Pulmonary Nodules/diagnostic imaging , Lung/pathology , Lung/diagnostic imaging , Biopsy/methods , Biopsy/instrumentation , AdultABSTRACT
Previous studies have shown that rapid on-site evaluation (ROSE) improves the diagnostic yield of bronchoscopy using endobronchial ultrasound with a guide sheath (EBUS-GS) for peripheral pulmonary lesions (PPL). While ROSE of imprint cytology from forceps biopsy has been widely discussed, there are few reports on ROSE of brush cytology. This study investigated the utility of ROSE of brush cytology during bronchoscopy. We retrospectively analyzed data from 214 patients who underwent bronchoscopy with EBUS-GS for PPL. The patients in the ROSE group had significantly higher diagnostic sensitivity through the entire bronchoscopy process than in the non-ROSE group (96.8% vs. 83.3%, P = 0.002). The use of ROSE significantly increased the sensitivity of brush cytology with Papanicolaou staining (92.9% vs. 75.0%, P < 0.001). When ROSE was sequentially repeated on brushing specimens, initially negative ROSE results converted to positive in 79.5% of cases, and the proportion of specimens with high tumor cell counts increased from 42.1 to 69.0%. This study concludes that ROSE of brush cytology improves the diagnostic accuracy of bronchoscopy and enhances specimen quality through repeated brushing.
Subject(s)
Bronchoscopy , Lung Neoplasms , Humans , Bronchoscopy/methods , Male , Female , Aged , Middle Aged , Retrospective Studies , Lung Neoplasms/pathology , Lung Neoplasms/diagnosis , Lung Neoplasms/diagnostic imaging , Rapid On-site Evaluation , Endosonography/methods , Cytodiagnosis/methods , Aged, 80 and over , Adult , Sensitivity and Specificity , CytologySubject(s)
Anastomosis, Surgical , Endosonography , Humans , Male , Anastomosis, Surgical/adverse effects , Anastomosis, Surgical/methods , Constriction, Pathologic/surgery , Constriction, Pathologic/etiology , Endosonography/methods , Esophageal Stenosis/surgery , Esophageal Stenosis/etiology , Esophagus/surgery , Esophagus/diagnostic imaging , Jejunostomy/methods , Jejunum/surgery , Ultrasonography, InterventionalABSTRACT
Acute cholecystitis, cholelithiasis, and gallbladder polyps represent the most gallbladder benign diseases. Endoscopic approaches for the management of these diseases were an alternative to standard laparoscopic cholecystectomy. These endoscopic approaches include transpapillary approaches via endoscopic retrograde cholangiopancreatography, transmural access approaches via endoscopic ultrasound, and endoscopic surgical approaches using natural orifice transluminal endoscopic surgery approaches. However, it's still uncertain which approach is associated with the superior clinical outcomes due to the lack of high-level evidence. Our review provides new insight into the endoscopic approaches for the management of gallbladder benign diseases, with the latest evidence included.
Subject(s)
Cholangiopancreatography, Endoscopic Retrograde , Cholelithiasis , Gallbladder Diseases , Polyps , Humans , Gallbladder Diseases/surgery , Cholangiopancreatography, Endoscopic Retrograde/methods , Polyps/surgery , Cholelithiasis/surgery , Endosonography/methods , Natural Orifice Endoscopic Surgery/methods , Cholecystitis, Acute/surgery , Cholecystectomy, Laparoscopic/methodsSubject(s)
Device Removal , Stents , Humans , Device Removal/methods , Endosonography/methods , Male , Female , Plastics , EndoscopesABSTRACT
Endoscopic ultrasound (EUS)-guided biliary drainage (EUS-BD) includes EUS-guided hepaticogastrostomy (EUS-HGS), EUS-guided choledochoduodenostomy (EUS-CDS), EUS-guided gallbladder drainage (EUS-GBD), EUS-guided antegrade stenting (EUS-AG) and EUS-guided rendezvous (EUS-RV). While EUS-HGS, EUS-CDS and EUS-GBD are transluminal drainage procedures, EUS-AG is a traspapillary drainage procedure and EUS-RV is a procedure intended to facilitate endoscopic retrograde cholangio pancreatography (ERCP) in instances of failed cannulation. These procedures were initially developed as options for endoscopic salvage of failed ERCP, but have evolved to become first-line interventions also for select indications over time as the technique and expertise improved. Several randomised controlled trials have demonstrated EUS-BD, especially EUS-CDS has similar or even better outcomes as compared to ERCP in malignant biliary obstruction. However, widespread adoption of these modalities is limited by the availability of expertise, steep learning curve, lack of standardization of techniques and cost. In this review, we aim to provide an overview of various EUS-BD procedures including the indications, accessories, technique, outcomes and follow-up of each of these procedures.
Subject(s)
Drainage , Endosonography , Stents , Humans , Endosonography/methods , Drainage/methods , Choledochostomy/methods , Cholangiopancreatography, Endoscopic Retrograde/methods , Cholestasis/surgery , Cholestasis/diagnostic imaging , Cholestasis/therapy , Gastrostomy/methods , Ultrasonography, Interventional/methods , Randomized Controlled Trials as TopicABSTRACT
The field of digestive endoscopy evolves continuously, offering -patients significant advances both in the diagnostic and therapeutic fields. The introduction of lumen--apposing metal stents has enabled innovation in several endoscopic techniques, including endoscopic ultrasound--guided gallbladder drainage, choledochoduodeno-stomy, gastroenteroanastomosis, and transgastric endoscopic retrograde cholangiopancreatography (EDGE). Compared to traditional treatment methods, these procedures have shown excellent success rates, coupled with a reduced risk of postoperative morbidity and lower costs.
L'endoscopie digestive connaît une évolution continue, offrant ainsi aux patients des avancées significatives, tant d'un point de vue diagnostique que thérapeutique. L'apparition des stents métalliques d'apposition luminale a permis le développement de plusieurs techniques endoscopiques innovantes telles que le drainage de la vésicule biliaire, la cholédocoduodénostomie, la gastro-entéro-anastomose et la cholangiopancréatographie rétrograde endoscopique transgastrique guidée par échoendoscopie (EDGE). Comparées aux méthodes de traitements traditionnelles, ces procédures ont montré d'excellents taux de réussite, un risque réduit de morbidité postopératoire et des coûts moindres.
Subject(s)
Endosonography , Humans , Endosonography/methods , Endosonography/instrumentation , Drainage/methods , Drainage/instrumentation , Stents , Ultrasonography, Interventional/methods , Cholangiopancreatography, Endoscopic Retrograde/methodsABSTRACT
BACKGROUND: The diagnostic yield of peripheral pulmonary lesions (PPLs) through endobronchial ultrasonography with a guide sheath transbronchial biopsy (EBUS-GS TBB) under virtual bronchoscopic navigation is unsatisfactory because radial EBUS probe is not always located within the lesion. Transbronchial needle aspiration with a guide sheath (GS-TBNA) has the potential to overcome the lower diagnostic yield by improving the relationship between the probe and the lesion and enabling repeated sampling while maintaining the location of a GS near the lesion. However, there are few data regarding the diagnostic yield and safety for diagnosing PPLs in this procedure. METHODS: We retrospectively analyzed consecutive 363 lesions (83 lesions underwent GS-TBNA/EBUS-GS TBB and 280 lesions underwent EBUS-GS TBB) at our institution between April 1, 2019 and March 31, 2022. We investigated the diagnostic efficacy and complications of GS-TBNA/EBUS-GS TBB and compared them with those of EBUS-GS TBB. RESULTS: The lesion size, distance from the hilum, presence of bronchus leading to the lesion, and EBUS images during the examination differed significantly between the two procedures. Logistic regression analysis adjusted for these 4 covariates revealed that GS-TBNA/EBUS-GS TBB was a significant factor affecting the diagnostic success of PPLs compared with EBUS-GS TBB (odds ratio=2.43, 95% CI=1.16-5.07, P=0.018). Neither procedure differed significantly in terms of complications (6.0% vs. 5.7%, P>0.999). CONCLUSION: GS-TBNA performed in addition to EBUS-GS TBB might be a promising sampling method for improving the diagnostic yield for PPLs without increasing the incidence of complications.